Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592006 | SCV000704793 | uncertain significance | not provided | 2016-12-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001398304 | SCV001600073 | likely benign | Alpha-1-antitrypsin deficiency | 2023-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350426 | SCV002651186 | likely benign | Inborn genetic diseases | 2021-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |